ÂÜÀòÂÒÂ×

Rob Woodman is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as a Non Executive Director at Enterprise Therapeutics and Complement Therapeutics, among others. Woodman has held the position of Partner at Panakes Partners since September 2021 and has extensive experience in leadership roles, including Chair and Non Executive Director positions at various companies such as TranSINE Therapeutics and DISCO Pharmaceuticals. Woodman's academic background includes a PhD in Oncology and Cancer Biology from the University of Cambridge and an MSc in Biochemistry and Molecular Biology from the University of Oxford.